Shattuck Labs, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: SL-325 · Hidradenitis Suppurativa Eligibility criteria changed
- Notable: RECEPTIVE-CD1 · SL-325 in Crohn's Disease Patients Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07934017 A Study of SL-325 in Participants With Hidradenitis Suppurativa | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 2 | 2 |
Disease areas by active trials
Crohn's Disease (1) · Hidradenitis Suppurativa (1)
Get alerts when Shattuck Labs, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.